The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic, ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...

President Donald Trump on Tuesday reiterated his plans to impose tariffs on pharmaceutical goods, threatening to charge as much as 200% as levies on a product category that has largely been immune ...

July 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva (TEVA.TA), opens new tab and Viatris (VTRS.O), opens ...

In Janssen Pharmaceuticals, Inc. v. Mylan Laboratories., the United States Court of Appeals for the Federal Circuit affirmed a district court ruling that a pharmaceutical dosing claim limitation was ...

(Reuters) - Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation. The following is a list of major prescription drugs whose ...

Intra-Cellular Therapies' Caplyta shows strong sales growth and label expansion potential, making it a valuable acquisition for Johnson & Johnson at $14 billion. JNJ's acquisition of ITCI is strategic ...

The Associated Press is suing three Trump administration officials over access to presidential events, citing freedom of speech in asking a federal judge to stop the blocking of its journalists. The ...

Invega Hafyera (paliperidone palmitate) is a prescription drug that’s used to treat schizophrenia. It’s given as an injection into your muscle by your doctor or another healthcare professional. Invega ...

Note: We’re tracking these changes closely and will update this piece as new developments emerge. Please feel free to reach out and share feedback or flag additional areas for review. 2025 marks the ...

President-elect Donald Trump has begun selecting high-ranking administration officials following last week’s election victory. Some former staffers will assume new positions, while others will not be ...